| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |